- Home
- AGFY vs HOWL Comparison
AGFY vs HOWL Comparison
Compare AGFY & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGFY
- HOWL
- Stock Information
- Founded
- AGFY 2016
- HOWL 2017
- Country
- AGFY United States
- HOWL United States
- Employees
- AGFY N/A
- HOWL N/A
- Industry
- AGFY Military/Government/Technical
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- AGFY Consumer Discretionary
- HOWL Health Care
- Exchange
- AGFY Nasdaq
- HOWL Nasdaq
- Market Cap
- AGFY 41.3M
- HOWL 47.1M
- IPO Year
- AGFY 2021
- HOWL 2021
- Fundamental
- Price
- AGFY $30.48
- HOWL $1.33
- Analyst Decision
- AGFY
- HOWL Strong Buy
- Analyst Count
- AGFY 0
- HOWL 3
- Target Price
- AGFY N/A
- HOWL $8.33
- AVG Volume (30 Days)
- AGFY 13.3K
- HOWL 199.3K
- Earning Date
- AGFY 08-08-2025
- HOWL 08-14-2025
- Dividend Yield
- AGFY N/A
- HOWL N/A
- EPS Growth
- AGFY N/A
- HOWL N/A
- EPS
- AGFY N/A
- HOWL N/A
- Revenue
- AGFY $12,260,000.00
- HOWL N/A
- Revenue This Year
- AGFY N/A
- HOWL N/A
- Revenue Next Year
- AGFY N/A
- HOWL N/A
- P/E Ratio
- AGFY N/A
- HOWL N/A
- Revenue Growth
- AGFY 186.99
- HOWL N/A
- 52 Week Low
- AGFY $2.71
- HOWL $0.60
- 52 Week High
- AGFY $84.44
- HOWL $4.18
- Technical
- Relative Strength Index (RSI)
- AGFY 67.36
- HOWL 58.20
- Support Level
- AGFY $28.93
- HOWL $1.12
- Resistance Level
- AGFY $35.63
- HOWL $1.29
- Average True Range (ATR)
- AGFY 2.21
- HOWL 0.08
- MACD
- AGFY 0.61
- HOWL 0.01
- Stochastic Oscillator
- AGFY 55.83
- HOWL 75.00
About AGFY Agrify Corporation
Agrify Corp is a developer of branded inventive solutions for the cannabis and hemp industries. Its Senorita brand offers consumers hemp-derived tetrahydrocannabinol (THC) beverages that mirror cocktails like a margarita - in three flavors - classic Lime Jalapeno Margarita, Mango Margarita, and Paloma. In addition to beverages, Agrify has also historically been a provider of inventive cultivation and extraction solutions for the cannabis industry. Its comprehensive extraction product line, which includes hydrocarbon, alcohol, solventless, post-processing, and lab equipment, empowers producers to maximize the quantity and quality of extract required for premium concentrates.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.